PapersPMID:30701554
Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 2 months
- Dose studied, every finding
- 3 g/day green cardamom for 10 weeks
- Population, every finding
- overweight or obese adults with type 2 diabetes mellitus
What moved
How to read these marks →“Compared to the control group, a significant decrease in serum HbA1C (-0.4%), insulin (-2.8 µIU dL-1 ), HOMA-IR (-1.7) and TG (-39.9 mg dL-1 ), and an increase in SIRT1 (2.3 ng mL-1 ) was observed in cardamom group.”
- Decreases glycated haemoglobin (HbA1c)
very limited
- Decreases HOMA-IR
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Overweight or obese type 2 diabetic patients; green cardamom 3 g vs rusk powder placebo for 10 weeks (abstract only)
- Participants
- 83
- Comparator
- placebo
- Duration
- 70 days
- Endpoints measured
- 8